1An example, line by line
This is the text of a real second-opinion report, published by the patient it belongs to1. The numbers match the notes underneath.
SLIDE CONSULTATION REPORT1
Service: 09/08/2021 Received: 09/14/2021 Reported: 09/16/20212
Clinical data: SECOND OPINION1
Diagnosis: ADNEXAL CARCINOMA3, CONSISTENT WITH4 MYOEPITHELIAL CARCINOMA (C44.609)5
Note: Immunostains demonstrate avid coexpression of CK5/6 and SOX-10, which suggests myoepithelial lineage. There is also partial expression of S100 protein.6 To exclude secretory carcinoma, TRK and mammaglobin immunostains remain pending. An addendum report with results will follow early next week when staining is complete.7
Invasion close to the inked surgical margin is noted. Additional excision to define a fully free surgical margin will be necessary.8
- Slide consultation, second opinion. The slides from the first biopsy were sent to another pathologist to read. For a rare tumor this is worth asking for: in one series most cases had first been given a different diagnosis2.
- The dates. Service is the day the tissue was taken. Received and reported are when the second laboratory got the slides and when it answered. Here the report came eight days after the tissue was taken.
- Adnexal carcinoma. A cancer of the skin's appendages: the sweat glands, oil glands and hair follicles. It says what kind of tissue the tumor comes from.
- Consistent with. Pathologists' wording for a diagnosis that the findings fit. It is less absolute than a flat statement, and is common when a tumor is rare or hard to classify.
- C44.609. A code for the location, used for billing and registries: skin of the left upper limb, including the shoulder. It describes the site, not the tumor type.
- The stains. Immunostains show which proteins the cells make. Most myoepithelial tumors stain for epithelial markers, such as keratins, together with S-100 protein3. This pathologist reads CK5/6 with SOX-10 as pointing to myoepithelial cells.
- Pending, and the addendum. Two more stains were ordered to rule out secretory carcinoma, a different gland cancer. Pending means the result is not in yet. Ask for the addendum when it arrives: it is part of the report.
- The margin. The surgeon's cut edge is marked with ink. Tumor close to the ink means cancer cells near the edge, so more tissue has to come out. Complete removal with clear margins was associated with better survival4.
2What else a report may give
Not every report has these. Each one bears on outlook, so ask if it is missing.
- Size
- Tumors larger than 5 cm did worse in the pooled literature4.
- Mitotic rate
- More than 10 dividing cells per 10 high-power fields was linked to worse survival4.
- Necrosis
- In one salivary series, no patient whose tumor lacked necrosis developed distant metastases5.
- Perineural and vascular invasion
- Tumor growing along nerves or into vessels. Recorded in 11 and 4 of 25 salivary tumors2.
- Grade
- How abnormal the cells look. Grading of this tumor is described as controversial5.
- Molecular tests
- FISH or sequencing for EWSR1, PLAG1 and other fusions, and a stain for INI136.
3What to ask for
- A copy of every report, including addenda that arrive later.
- A second opinion on the slides from a center that sees these tumors.
- Whether fusion testing has been done, and if not, whether it can be.
- Where the slides and tissue blocks are stored, in case another center needs them.
The first-steps guide puts these in order. The glossary explains the terms.
4References
- Saddington P. Today, I'm Supposed to Die. TheAgileVC, 20 March 2025. source ↩
- Savera AT, Sloman A, Huvos AG et al. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. The American journal of surgical pathology, 2000. PubMed ↩
- Jo VY, Fletcher CD. Myoepithelial neoplasms of soft tissue: an updated review of the clinicopathologic, immunophenotypic, and genetic features. Head and neck pathology, 2015. PubMed ↩
- Giridhar P, Gupta P, Mallick S et al. Impact of adjuvant therapy on survival in patients with myoepithelial carcinoma: A systematic review and individual patient data analysis of 691 patients. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019. PubMed ↩
- Kong M, Drill EN, Morris L et al. Prognostic factors in myoepithelial carcinoma of salivary glands: a clinicopathologic study of 48 cases. The American journal of surgical pathology, 2015. PubMed ↩
- Michal M, Malik F, Mansour B et al. FET-Rearranged Myoepithelial Tumors Are Clinically Heterogeneous and Epigenetically Distinct from PLAG1-Rearranged Adnexal and Salivary Gland Myoepithelial Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2026. PubMed ↩